Stuttgart - Delayed Quote EUR
CARISMA Therapeutics Inc (W2J.SG)
0.1953
+0.0264
+(15.63%)
At close: May 2 at 9:26:23 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-59,917
-59,917
-81,177
-5,116
-37,328
Investing Cash Flow
-123
-123
72,408
-32,560
-1,871
Financing Cash Flow
344
344
62,180
33,319
15,962
End Cash Position
17,909
17,909
77,605
24,194
28,551
Interest Paid Supplemental Data
192
192
352
98
--
Capital Expenditure
-123
-123
-1,132
-4,660
-1,871
Issuance of Capital Stock
2,392
2,392
31,237
--
16,328
Issuance of Debt
--
--
--
35,000
--
Repayment of Debt
-1,429
-1,429
-1,301
-865
--
Free Cash Flow
-60,040
-60,040
-82,309
-9,776
-39,199
12/31/2021 - 3/8/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade